Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

Target Audience
This educational activity is directed towards ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with dry eye disease and meibomian gland dysfunction.

Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which two experts discuss the management of meibomian gland dysfunction (MGD)-associated dry eye disease (DED). In this activity, the faculty focus on the etiology of MGD-associated DED and current and emerging therapeutic strategies for its management. Their discussion is enriched with the use of video animation to illustrate the pathophysiology of MGD and mechanisms of action of emerging agents. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of MGD-associated DED and to improve outcomes for their patients with this disease.

Learning Objectives
Upon completion of this activity, participants should be better able to:
Describe the impact that MGD-associated DED has on patients’ quality of life
Assess the efficacy and safety of currently available agents used for the treatment of MGD-associated DED
Identify the MOAs of new and emerging agents for the treatment of MGD-associated DED
Evaluate clinical trial data for new and emerging agents in the treatment of MGD-associated DED